Principal Financial Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,969
| Closed | -$233K | – | 2388 |
|
|
2020
Q2 | $233K | Buy |
12,969
+1,253
| +11% | +$22.5K | ﹤0.01% | 2146 |
|
|
2020
Q1 | $84K | Sell |
11,716
-9,350
| -44% | -$67K | ﹤0.01% | 2130 |
|
|
2019
Q4 | $503K | Buy |
21,066
+564
| +3% | +$13.5K | ﹤0.01% | 1946 |
|
|
2019
Q3 | $550K | Buy |
20,502
+1,946
| +10% | +$52.2K | ﹤0.01% | 1927 |
|
|
2019
Q2 | $504K | Sell |
18,556
-156
| -0.8% | -$4.24K | ﹤0.01% | 1959 |
|
|
2019
Q1 | $649K | Buy |
+18,712
| New | +$649K | ﹤0.01% | 1888 |
|
|
2018
Q4 | – | Sell |
-22,282
| Closed | -$593K | – | 2357 |
|
|
2018
Q3 | $593K | Buy |
22,282
+3,070
| +16% | +$81.7K | ﹤0.01% | 1933 |
|
|
2018
Q2 | $726K | Buy |
19,212
+1,054
| +6% | +$39.8K | ﹤0.01% | 1897 |
|
|
2018
Q1 | $593K | Sell |
18,158
-36,741
| -67% | -$1.2M | ﹤0.01% | 1916 |
|
|
2017
Q4 | $2.67M | Sell |
54,899
-7,230
| -12% | -$352K | ﹤0.01% | 1713 |
|
|
2017
Q3 | $3.36M | Sell |
62,129
-564
| -0.9% | -$30.5K | ﹤0.01% | 1661 |
|
|
2017
Q2 | $3.52M | Buy |
62,693
+371
| +0.6% | +$20.8K | ﹤0.01% | 1646 |
|
|
2017
Q1 | $2.44M | Buy |
62,322
+202
| +0.3% | +$7.92K | ﹤0.01% | 1702 |
|
|
2016
Q4 | $1.39M | Buy |
62,120
+9,657
| +18% | +$217K | ﹤0.01% | 1767 |
|
|
2016
Q3 | $1.19M | Buy |
52,463
+43,814
| +507% | +$995K | ﹤0.01% | 1746 |
|
|
2016
Q2 | $204K | Buy |
+8,649
| New | +$204K | ﹤0.01% | 2026 |
|
|
2016
Q1 | – | Sell |
-7,961
| Closed | -$410K | – | 2214 |
|
|
2015
Q4 | $410K | Hold |
7,961
| – | – | ﹤0.01% | 1883 |
|
|
2015
Q3 | $339K | Buy |
7,961
+1,011
| +15% | +$43.1K | ﹤0.01% | 1923 |
|
|
2015
Q2 | $317K | Buy |
6,950
+138
| +2% | +$6.29K | ﹤0.01% | 1941 |
|
|
2015
Q1 | $259K | Buy |
+6,812
| New | +$259K | ﹤0.01% | 1965 |
|